Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A study found that minoxidil can damage the hearts of dogs and pigs, cautioning its use in humans.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Using finasteride with TIP extends time off period for prostate cancer patients.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

Cetuximab can cause eyelash growth, which is rare but manageable.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

UVB radiation changes the levels of certain microRNAs in skin cells, which may affect cell survival and hair growth.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

PRP did not significantly regrow hair in alopecia areata totalis patients.